Top Markets
#1 Ontology Gas Ontology Gas +40.10%
#2 Verus Coin Verus Coin +22.50%
#3 EXOD EXOD +22.08%
#4 Status Status +19.99%
#5 Geodnet Geodnet +14.90%
#6 ETHGas ETHGas +13.90%
#7 The Black Bull The Black Bull +12.16%
#8 Fake World Assets Fake World Assets +11.14%
#9 Curve DAO Curve DAO +10.88%
#10 Pons Pons +10.54%
Coin of the day
Ontology Gas Ontology Gas
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Classement en actions #25521
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Prix de l'action
$9.81
Dernière synchronisation: 2025-03-18
Capitalisation boursière
$48.68M
Changement (1 jour)
1.55%
Changement (1 an)
0.00%
Pays
US
Échange AlloVir, Inc. (ALVR)

Catégorie

Healthcare
Nombre d'actions en circulation pour AlloVir, Inc. (ALVR)
Nombre d'actions en circulation au June 2026: 23.80M
Selon les derniers rapports financiers et le cours de l'action de AlloVir, Inc., le nombre actuel d'actions en circulation est de 23.80M. À la fin de December 2023, l'entreprise avait 4.47M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de AlloVir, Inc. (ALVR) de 2018 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 23.80M 379.57%
2024 4.96M 10.90%
2023 4.47M 35.75%
2022 3.30M 22.10%
2021 2.70M 133.42%
2020 1.16M -36.07%
2019 1.81M 38.40%
2018 1.31M 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 966.93%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 161.31%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 1,932.06%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 1,564.05%
US